In this video, Peter A. Humphrey, MD, PhD, provides an overview of some important takeaways in bladder and kidney cancer that were discussed at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Humphrey is a professor of pathology and the director of genitourinary pathology at the Yale University School of Medicine in New Haven, Connecticut.
Adjuvant pembrolizumab improves overall survival in certain patients with renal cell carcinoma
November 1st 2023Adjuvant pembrolizumab improved overall survival compared with placebo in patients with renal cell carcinoma at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.
2 Clarke Drive
Cranbury, NJ 08512